Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05947500
What this trial is testing

Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial

Who this might be right for
Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8Locally Advanced Merkel Cell Carcinoma+3 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00005807
What this trial is testing

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Who this might be right for
Breast CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Albert Einstein College of Medicine 40
Large-scale testing (Phase 3)Study completedNCT00017407
What this trial is testing

Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00112671
What this trial is testing

Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+4 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Not applicableUnknownNCT01372787
What this trial is testing

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
AnxietyFatigueNausea and Vomiting+20 more
Gynecologic Oncology Group 103
Post-approval studies (Phase 4)Study completedNCT03285763
What this trial is testing

Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 619
Testing effectiveness (Phase 2)Looking for participantsNCT07579195
What this trial is testing

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Who this might be right for
Muscle Invasive Bladder CarcinomaStage III Bladder Cancer AJCC v8Stage IV Bladder Cancer AJCC v8
University of Washington 12
Not applicableStudy completedNCT00896675
What this trial is testing

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 352
Not applicableStudy completedNCT02135757
What this trial is testing

Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
PeriPharm 23
Post-approval studies (Phase 4)Study completedNCT02447328
What this trial is testing

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced orMetastatic Breast Cancer
AstraZeneca 83
Not applicableStudy completedNCT03649230
What this trial is testing

Observational Study on the Use of Akynzeo® in Patients Receiving HEC

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Purdue Pharma, Canada 207
Testing effectiveness (Phase 2)Study completedNCT04789200
What this trial is testing

Phase 2 Study of NX9 for Delineation of Bowel Anatomy

Who this might be right for
GI CarcinomaGI Disorders
Nextrast, Inc. 32
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Early research (Phase 1)Study completedNCT01861509
What this trial is testing

BP-C1 in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast CancerStage IV Breast Cancer
Meabco A/S 10
Testing effectiveness (Phase 2)UnknownNCT04180501
What this trial is testing

SRS Sequential Sindilimab in Brain Metastasis of NSLSC

Who this might be right for
NSCLC Stage IVBrain MetastasesSRS+1 more
Xiaorong Dong 25
Testing effectiveness (Phase 2)Study completedNCT01359592
What this trial is testing

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 159
Early research (Phase 1)Ended earlyNCT00023634
What this trial is testing

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Who this might be right for
Brain TumorsGastric CancerOvarian Cancer+1 more
SWOG Cancer Research Network 14
Next Page